Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: A literature-based study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 8, 2013, Pages 924-931

  Berks, D ^a   Hoedjes, M ^a   Raat, H ^a   Duvekot, J J ^a   Steegers, E A P ^a   Habbema, J D F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; lifestyle interventions; pre eclampsia

Indexed keywords

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIASTOLIC BLOOD PRESSURE; DIET; EXERCISE; FEMALE; GESTATIONAL AGE; HEALTH PROMOTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MATERNAL CARE; MATERNAL HYPERTENSION; PREDICTION; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROCAM SCORE; PROTEINURIA; REYNOLDS RISK SCORE; RISK REDUCTION; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; LIFESTYLE; PREGNANCY; REVIEW; RISK; RISK FACTOR;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84879247065     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12191     Document Type: Article

References (68)

1. Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R,. Pre-eclampsia. Lancet 2010; 376: 631-44.
2. Bellamy L, Casas JP, Hingorani AD, Williams DJ,. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974-85.
3. Sibai B, Dekker G, Kupferminc M,. Pre-eclampsia. Lancet 2005; 365: 785-99.
4. Srinivas SK, Sammel MD, Bastek J, Ofori E, Andrela CM, Wolfe ML, et al. Evaluating the association between all components of the metabolic syndrome and pre-eclampsia. J Matern Fetal Neonatal Med 2009; 22: 501-9.
5. Sattar N, Greer IA,. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325: 157-60.
6. Newstead J, Von Dadelszen P, Magee LA,. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther 2007; 5: 283-94.
7. Craici I, Wagner S, Garovic VD,. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008; 2: 249-59.
8. Mathers CD, Bernard C, Iburg KM, Inoue M, Ma Fat D, Shibuya K, et al. Annex B: data sources, methods and results. In: Global Burden of Disease: 2004 update, Switzerland: WHO; 2008. pp. 98-118.
9. Ketola E, Sipila R, Makela M,. Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. Ann Med 2000; 32: 239-51.
10. Fleming P, Godwin M,. Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician 2008; 54: 1706-13.
11. Berks D, Steegers EA, Molas M, Visser W,. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 2009; 114: 1307-14.
12. Cui J,. Overview of risk prediction models in cardiovascular disease research. Ann Epidemiol 2009; 19: 711-7.
13. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS,. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009; 119: 3078-84.
14. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675-87.
15. Assmann G, Cullen P, Schulte H,. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310-5.
16. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
17. Moons KG, Bots ML, Salonen JT, Elwood PC, Freire de Concalves A, Nikitin Y, et al. Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health 2002; 56 (Suppl 1): i30-6.
18. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005; 34: 413-21.
19. Ridker PM, Buring JE, Rifai N, Cook NR,. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-9.
20. Hoedjes M, Berks D, Vogel I, Franx A, Visser W, Duvekot JJ, et al. Effect of postpartum lifestyle interventions on weight loss, smoking cessation, and prevention of smoking relapse: a systematic review. Obstet Gynecol Surv 2010; 65: 631-52.
21. Ebrahim S, Beswick A, Burke M, Davey Smith G,. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2006; 4: CD001561.
22. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ,. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 2010; 122: 579-84.
23. Folsom AR, Ohira T, Yamagishi K, Cushman M,. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost 2009; 7: 1774-8.
24. Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J,. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 2008; 118: 1659-67.
25. Hoedjes M, Berks D, Vogel I, Franx A, Duvekot JJ, Oenema A, et al. Motivators and Barriers to a Healthy Postpartum Lifestyle in Women at Increased Cardiovascular and Metabolic Risk: A Focus-Group Study. Hypertens Pregnancy 2012; 31: 147-55.
26. Hoedjes M, Berks D, Vogel I, Duvekot JJ, Oenema A, Franx A, et al. Preferences for postpartum lifestyle counseling among women sharing an increased cardiovascular and metabolic risk: a focus group study. Hypertens Pregnancy 2011; 30: 83-92.
27. Xhyheri B, Bugiardini R,. Diagnosis and treatment of heart disease: are women different from men? Prog Cardiovasc Dis 2010; 53: 227-36.
28. He S, Silveira A, Hamsten A, Blomback M, Bremme K,. Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost 1999; 81: 538-42.
29. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA,. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003; 42: 39-42.
30. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89: 6239-43.
31. Kaaja R, Kinnunen T, Luoto R,. Regional differences in the prevalence of pre-eclampsia in relation to the risk factors for coronary artery disease in women in Finland. Eur Heart J 2005; 26: 44-50.
32. Girouard J, Giguere Y, Moutquin JM, Forest JC,. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007; 49: 1056-62.
33. Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A,. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2007; 26: 39-50.
34. Berends AL, De Groot CJ, Sijbrands EJ, Sie MP, Benneheij SH, Pal R, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008; 51: 1034-41.
35. Gaugler-Senden IP, Berends AL, De Groot CJ, Steegers EA,. Severe, very early onset preeclampsia: subsequent pregnancies and future parental cardiovascular health. Eur J Obstet Gynecol Reprod Biol 2008; 140: 171-7.
36. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR,. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 2009; 114: 961-70.
37. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200: 58-e1.
38. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326: 845-9.
39. Edlow AG, Srinivas SK, Elovitz MA,. Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2009; 200: e60-2.
40. Marin R, Gorostidi M, Portal CG, Sanchez M, Sanchez E, Alvarez J,. Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy 2000; 19: 199-209.
41. Roes EM, Sieben R, Raijmakers MT, Peters WH, Steegers EA,. Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia. Hypertens Pregnancy 2005; 24: 259-71.
42. Rigo J Jr, Boze T, Derzsy Z, Derzbach L, Treszl A, Lazar L, et al. Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 128: 148-51.
43. Valdes G, Quezada F, Marchant E, Von Schultzendorff A, Moran S, Padilla O, et al. Association of remote hypertension in pregnancy with coronary artery disease: a case-control study. Hypertension 2009; 53: 733-8.
44. Gillett PA, Eisenman PA,. The effect of intensity controlled aerobic dance exercise on aerobic capacity of middle-aged, overweight women. Res Nurs Health 1987; 10: 383-90.
45. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. Arch Intern Med 1990; 150: 153-62.
46. Eriksson KF, Lindgarde F,. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991; 34: 891-8.
47. Sjostrom M, Yngve A, Poortvliet E, Warm D, Ekelund U,. Diet and physical activity-interactions for health; public health nutrition in the European perspective. Public Health Nutr 1999; 2: 453-9.
48. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134: 1-11.
49. Wall MA, Severson HH, Andrews JA, Lichtenstein E, Zoref L,. Pediatric office-based smoking intervention: impact on maternal smoking and relapse. Pediatrics 1995; 96: 622-8.
50. Severson HH, Andrews JA, Lichtenstein E, Wall M, Akers L,. Reducing maternal smoking and relapse: long-term evaluation of a pediatric intervention. Prev Med 1997; 26: 120-30.
51. Glasgow RE, Whitlock EP, Eakin EG, Lichtenstein E,. A brief smoking cessation intervention for women in low-income planned parenthood clinics. Am J Public Health 2000; 90: 786-9.
52. Solomon LJ, Flynn BS,. Telephone support for pregnant smokers who want to stop smoking. Health Promot Pract 2005; 6: 105-8.
53. Solomon LJ, Marcy TW, Howe KD, Skelly JM, Reinier K, Flynn BS,. Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches? Prev Med 2005; 40: 306-13.
54. Baron JA, Gleason R, Crowe B, Mann JI,. Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract 1990; 40: 137-41.
55. Manning JM, Dooly-Manning CR, White K, Kampa I, Silas S, Kesselhaut M, et al. Effects of a resistive training program on lipoprotein-lipid levels in obese women. Med Sci Sports Exerc 1991; 23: 1222-6.
56. Simkin-Silverman L, Wing RR, Hansen DH, Klem ML, Pasagian-Macaulay AP, Meilahn EN, et al. Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Prev Med 1995; 24: 509-17.
57. Janssen I, Fortier A, Hudson R, Ross R,. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002; 25: 431-8.
58. Cheng C, Graziani C, Diamond JJ,. Cholesterol-lowering effect of the Food for Heart Nutrition Education Program. J Am Diet Assoc 2004; 104: 1868-72.
59. Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J,. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ 2007; 177: 859-65.
60. Lovelady CA, Nommsen-Rivers LA, McCrory MA, Dewey KG,. Effects of exercise on plasma lipids and metabolism of lactating women. Med Sci Sports Exerc 1995; 27: 22-8.
61. Leermakers EA, Anglin K, Wing RR,. Reducing postpartum weight retention through a correspondence intervention. Int J Obes Relat Metab Disord 1998; 22: 1103-9.
62. McCrory MA, Nommsen-Rivers LA, Mole PA, Lonnerdal B, Dewey KG,. Randomized trial of the short-term effects of dieting compared with dieting plus aerobic exercise on lactation performance. Am J Clin Nutr 1999; 69: 959-67.
63. Lovelady CA, Garner KE, Moreno KL, Williams JP,. The effect of weight loss in overweight, lactating women on the growth of their infants. N Engl J Med 2000; 342: 449-53.
64. O'Toole ML, Sawicki MA, Artal R,. Structured diet and physical activity prevent postpartum weight retention. J Womens Health (Larchmt) 2003; 12: 991-8.
65. Lovelady CA, Stephenson KG, Kuppler KM, Williams JP,. The effects of dieting on food and nutrient intake of lactating women. J Am Diet Assoc 2006; 106: 908-12.
66. Kinnunen TI, Pasanen M, Aittasalo M, Fogelholm M, Weiderpass E, Luoto R,. Reducing postpartum weight retention-a pilot trial in primary health care. Nutr J 2007; 6: 21-9.
67. de Castro MB, Kac G, de Leon AP, Sichieri R,. High-protein diet promotes a moderate postpartum weight loss in a prospective cohort of Brazilian women. Nutrition 2009; 25: 1120-8.
68. Ostbye T, Krause KM, Lovelady CA, Morey MC, Bastian LA, Peterson BL, et al. Active Mothers Postpartum: a randomized controlled weight-loss intervention trial. Am J Prev Med 2009; 37: 173-80.